McEwen Mining Inc. (MUX) Financials Nov 14, 2014, 6:47

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
McEwen Mining Inc. (MUX) Financials Nov 14, 2014, 6:47 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for McEwen Mining Inc.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 5.97M 45.98M
Cost of Goods Sold (COGS) incl. D&A 9.63M 20.18M 44.08M 75.29M 62.21M
COGS excluding D&A 8.24M 19.21M 42.98M 73.81M 59.28M
Depreciation & Amortization Expense 1.39M 969,000 1.1M 1.48M 2.93M
Depreciation 1.39M 969,000 1.1M 1.48M 2.93M
Amortization of Intangibles - - - - 0
Gross Income (9.63M) (20.18M) (44.08M) (69.32M) (16.23M)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 9.03M 9.76M 16.14M 24.05M 19.43M
Research & Development 0 0 1.75M 0 847,000
Other SG&A 9.03M 9.76M 14.39M 24.05M 18.59M
Other Operating Expense 0 0 0 0 0
Unusual Expense 16.58M 5.88M 3.39M 26.16M 158.28M
EBIT after Unusual Expense (16.58M) (5.88M) (3.39M) (26.16M) (158.28M)
Non Operating Income/Expense 1.03M 626,000 1.36M 4.57M (8.28M)
Non-Operating Interest Income 127,000 112,000 202,000 228,000 262,000
Equity in Affiliates (Pretax) 0 0 0 20.84M 846,000
Interest Expense 0 15,000 0 0 0
Gross Interest Expense 0 15,000 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income (34.07M) (35.09M) (62.05M) (93.9M) (201.11M)
Income Tax (6.38M) (2M) (180,000) (27.24M) (53.37M)
Income Tax - Current Domestic 0 - - - -
Income Tax - Current Foreign 0 - - - -
Income Tax - Deferred Domestic (6.38M) - - - -
Income Tax - Deferred Foreign 0 - - - -
Income Tax Credits 0 - - - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (27.7M) (33.09M) (61.87M) (66.65M) (147.74M)
Minority Interest Expense 0 0 0 0 0
Net Income (27.7M) (33.09M) (61.87M) (66.65M) (147.74M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (27.7M) (33.09M) (61.87M) (66.65M) (147.74M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (27.7M) (33.09M) (61.87M) (66.65M) (147.74M)
EPS (Basic) (0.24) (0.26) (0.43) (0.26) (0.50)
Basic Shares Outstanding 117.54M 127.77M 143.54M 261.22M 297.04M
EPS (Diluted) (0.24) (0.26) (0.43) (0.26) (0.50)
Diluted Shares Outstanding 117.54M 127.77M 143.54M 261.22M 297.04M
EBITDA (17.27M) (28.97M) (59.12M) (91.89M) (32.73M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 4

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 2

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 5

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Eye Class Action Lawsuit Against Smart Digital Group

Updated Category News Views 142

Class Action Lawsuit Overview Against Smart Digital Group Ltd. The Rosen Law Firm, recognized for advocating for investor rights globally, has initiated a class action lawsuit aimed at purchasers of securities from Smart Digital Group Ltd. (NASDAQ: SDM). This lawsuit encompasses transactions that occurred between May 5, 2025, and September 26, 2025. Investors who made...

Continue Reading
Join the Class Action Against Zeta Global Holdings Today

Updated Category News Views 108

Join the Class Action Against Zeta Global Holdings Levi & Korsinsky, LLP is reaching out to concerned investors in Zeta Global Holdings Corp. regarding a class action lawsuit that could affect many shareholders. This lawsuit aims to recover losses incurred by those negatively impacted by alleged securities fraud during a specific timeframe. Understanding the Class Action...

Continue Reading
EverBank Strengthens Equipment Finance with New Division

Updated Category News Views 209

EverBank Expands Its Equipment Finance Horizons EverBank is embarking on an exciting new journey by launching a Corporate Asset Finance division, enhancing its equipment finance capabilities significantly. This innovative step is set to offer structured equipment loans and leases to large and middle-market companies, ensuring that they receive the support they need to...

Continue Reading
USA Health and RLDatix Team Up for Enhanced Patient Safety

Updated Category News Views 122

USA Health and RLDatix Team Up for Enhanced Patient Safety In a significant development in the healthcare sector, USA Health has announced an expansion of its partnership with RLDatix, a trailblazer in healthcare operations software. This collaboration is designed to foster a safer healthcare environment, ensuring patients receive the highest standard of care. Empowering...

Continue Reading
Exciting Advancements in COVID-19 Vaccine Technology by Soligenix

Updated Category News Views 289

Soligenix’s CiVax™: A New Approach to COVID-19 Vaccination In a remarkable leap forward in the fight against COVID-19, Soligenix, Inc. (NASDAQ: SNGX), a biopharmaceutical company dedicated to rare disease treatments, has announced significant findings about its innovative vaccine candidate, CiVax™. This thermostabilized subunit vaccine has demonstrated promising...

Continue Reading